Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-10-16FDA Approved: LIVALO — Supplemental Application (Kowa Pharmaceuticals America, Inc.)
FDA approved a supplemental application for LIVALO (pitavastatin calcium) submitted by Kowa Pharmaceuticals America, Inc.
-
FDA approval · 2013-09-30FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for simvastatin submitted by Accord Healthcare, Inc.
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: A Study to Evaluate the Lipid Regulating Effects of TRIA-662 [Phase 2, Phase 3]
A clinical trial update notes the completion of Phase 2 and Phase 3 studies evaluating the lipid-lowering effects of TRIA-662 in hyperlipide…
-
CLINICAL_TRIALS trial_result · 2013-09-11Clinical Trial Update: Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS) [Phase 4]
A Phase 4 clinical trial evaluating how statins affect progression of lipid-rich plaque in coronary artery disease and hyperlipidemia using …
-
CLINICAL_TRIALS trial_result · 2013-09-11Clinical Trial Update: Lipid Metabolism in Gestational Diabetes
A completed clinical trial at Baystate Medical Center evaluated lipid metabolism in gestational diabetes with hyperlipidemia; results were p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia [Phase 3]
Phase 3 study evaluating the efficacy and safety of combined irbesartan and atorvastatin therapy in adults with hypertension and hyperlipide…
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers [Phase 1]
Phase 1 clinical trial by LG Life Sciences evaluates the safety and potential interaction between valsartan and rosuvastatin in healthy male…
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of the fixed-dose combination VR 160/20 mg compared with co-administration of valsartan …
-
FDA approval · 2013-08-06FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., authorizing a new generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine [Phase 1]
Phase 1 study evaluating whether atorvastatin affects the pharmacokinetics of Telmisartan/S-amlodipine in patients with essential hypertensi…
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. [Phase 1]
A Phase 1 trial evaluating whether telmisartan/S-amlodipine affects the pharmacokinetics of atorvastatin has completed.
-
FDA approval · 2013-07-31FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the fixed-dose combination of amlodipine and atorvastatin, with Prasco Laboratories listed a…
-
FDA approval · 2013-07-26FDA Approved: LOVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for lovastatin, authorizing changes requested in the application (such as l…
-
FDA approval · 2013-07-26FDA Approved: FENOFIBRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for fenofibrate from Mylan Pharmaceuticals Inc., approving changes to the approved generic product.
-
FDA approval · 2013-07-26FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Quallent)
FDA approved a supplemental application for Pravastatin Sodium submitted by Quallent.
-
FDA approval · 2013-07-26FDA Approved: FENOFIBRATE — Original Application (Apotex Corp.)
The FDA approves the original (ANDA) application for fenofibrate from Apotex Corp., granting generic approval for the lipid-lowering medicin…
-
FDA approval · 2013-06-28FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc. to update lab…
-
FDA approval · 2013-06-28FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc., under NDA 022362…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Eating Peanuts for Health [NA]
A completed Purdue University-sponsored clinical trial evaluated the health effects of peanut consumption in adults with obesity and overwei…
-
CLINICAL_TRIALS research · 2013-06-18Clinical Trial Update: Identification in Obese Patients of the Mechanism Involved in Intramuscular Lipid Accumulation [NA]
A completed clinical trial at University Hospital, Montpellier examined the mechanism behind intramuscular lipid accumulation in obese patie…
-
CLINICAL_TRIALS trial_result · 2013-06-13Clinical Trial Update: Vitamin D and Omega-3 Inhibit Metabolic Syndrome [Phase 3]
Phase 3 trial update suggests Vitamin D and Omega-3 may inhibit metabolic syndrome components. The results come from a completed Phase 3 stu…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia [Phase 3]
Phase 3 trial evaluating imported probucol for hyperlipidemia has completed, reporting results on its efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Efficacy and Safety of Kochujang Pills on Blood Lipids Profiles in Hyperlipidemia Subjects [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating Kochujang Pills for efficacy and safety in lowering blood lipid levels in adults with hyperlipidemia h…
-
CLINICAL_TRIALS research · 2013-05-24Clinical Trial Update: Effects of Resistance and Aerobic Exercise on Cardiovascular Health [Phase 2]
Phase 2 clinical trial sponsored by Duke University evaluated the effects of resistance and aerobic exercise on cardiovascular health.
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Efficacy of Almonds Added to Chronic Statin Therapy [Phase 4]
This Phase 4 trial assessed whether adding almond consumption to ongoing statin therapy improves lipid outcomes in people with hyperlipidemi…